Updates are available Correction dated 2024-06-11
Click to view Correction: https://doi.org/10.1186/s40478-024-01789-w
-
Authors
Brown, Jennifer L.
Hart, Damyan W.
Boyle, Gabriel E.
Brown, Taylor G.
LaCroix, Michael
Baraibar, Andrés M.
Pelzel, Ross
Kim, Minwoo
Sherman, Mathew A.
Boes, Samuel
Sung, Michelle
Cole, Tracy
Lee, Michael K.
Araque, Alfonso
Lesné, Sylvain E. https://orcid.org/0000-0001-9411-1868
-
Funding
Funding for this research was provided by:
National Institute on Aging (RF1-AG044342, RF1-AG070296, R21-AG065693, R01-AG062135, R01-AG077743)
National Institute of Neurological Disorders and Stroke (R01-NS092918, R56-NS113549, NS108686, NS086074, NS092093, T32-NS105604)
University of Minnesota Foundation
Institute for Translational Neuroscience (Bridge funding)
- License Information
-
More Information
Article History
Received: 23 August 2022
Accepted: 18 November 2022
First Online: 14 December 2022
Change Date: 11 June 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s40478-024-01789-w
Declarations
:
: The University of Minnesota Institutional Review Board approved this study.
: All authors discussed the results, commented on this manuscript and gave approval for publication.
: Unless stated subsequently, the authors declare that they have no competing interests. T. Cole: Other Research Support (receipt of drugs, supplies, equipment or other in-kind support); Provided drug (mouse alpha-synuclein ASO).
